Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle

American Journal of Physiology - Endocrinology and Metabolism

Volumn 292, Issue 2, 2007, Pages

  Frost, Robert A ^a   Nystrom, Gerald J ^a   Jefferson, Leonard S ^a   Lang, Charles H ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Insulin like growth factor I; Leucine; Muscle atrophy F box protein; Muscle RING finger 1; Muscle wasting; Ubiquitin ligase

Indexed keywords

ATROGIN 1; CYTOKINE; DEXAMETHASONE; ENDOTOXIN; GLUCOCORTICOID; LEUCINE; MESSENGER RNA; MIFEPRISTONE; MUSCLE PROTEIN; MUSCLE RING FINGER 1 PROTEIN; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; HORMONE SYNTHESIS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUTRITION; PERITONITIS; PRIORITY JOURNAL; RAT; SEPSIS; SKELETAL MUSCLE; UPREGULATION;

ANIMALS; CORTICOSTERONE; CYTOKINES; DIET; GLUCOCORTICOIDS; INSULIN; MALE; MUSCLE PROTEINS; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; SKP CULLIN F-BOX PROTEIN LIGASES; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN-PROTEIN LIGASES;

EID: 33846875462     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00359.2006     Document Type: Article

References (62)

1. Anthony JC, Anthony TG, Kimball SR, Jefferson LS. Signaling pathways involved in translational control of protein synthesis in skeletal muscle by leucine. J Nutr 131: 856S-860S, 2001.
2. Bodine SC, Latres E, Baumheter S, Lai VK, Nunez L, Clarke BA, Pouevmirou WT, Panaro FJ, Na EM, Stitt TN, Yancopoulos GD, Glass DJ. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708, 2001.
3. Brough WA, Home G, Blout A, Irving MH, Jeejeebhoy KN. Effects of nutrient intake, surgery, sepsis, and long term administration of steroids on muscle function. Br Med J (Clin Red Ed) 293: 983-988, 1986.
4. Buse MG, Reid SS. Leucine: a possible regulator of protein turnover in muscle. J Clin Invest 56: 1250-1261, 1975.
5. Chrysis D, Underwood LE. Regulation of components of the ubiquitin system by insulin-like growth factor I and growth hormone in skeletal muscle or rats made catabolic with dexamethasone. Endocrinology 140: 5635-5641, 1999.
6. Combaret L, Tilignac T, Claustre A, Voisin L, Taillandier D, Obled C, Tanaka K, Attaix D. Torbafylline (HWA 448) inhibits enhanced skeletal muscle ubiquitin-proteasome-dependent proteolysis in cancer and septic rats. Biochem J 361: 185-192, 2002.
7. Cooney R, Kimball SR, Eckman R, Maish G, Shumate M, Vary TC. TNF-binding protein ameliorates inhibition of skeletal muscle protein synthesis during sepsis. Am J Physiol Endocrinol Metab 276: E611-E619, 1999.
8. Crozier SJ, Kimball SR, Emmert SW, Anthony JC, Jefferson LS. Oral leucine administration stimulates protein synthesis in rat skeletal muscle. J Nutr 135: 376-382, 2005.
9. Dehoux MJ, van Beneden RP, Gernandez-Celemin L, Lause PL, Thissen JP. Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection. FEBS Lett 544: 214-217, 2003.
10. Fan J, Wojnar MM, Theodorakis M, Lang CH. Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF binding proteins by interleukin-1. Am J Physiol Regul Integr Comp Physiol 270: R621-R629, 1996.
11. Fang C, Li BG, Sun X, Hasselgren PO. Insulin-like growth factor I reduces ubiquitin and ubiquitin-conjugating enzyme gene expression but does not inhibit muscle proteolysis in septic rats. Endocrinology 141: 2743-2751, 2000.
12. Fang CH, Li BG, Wang JJ, Fischer JE, Hasselgren PO. Treatment of burned rats with insulin-like growth factor I inhibits the catabolic response in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 275: R1091-R1098, 1998.
13. Fareed MU, Evenson AR, Wei W, Menconi M, Poylin V, Petkova V, Pignol B, Hasselgren PO. Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression. Am J Physiol Regul Integr Comp Physiol 290: R1589-R1597, 2006.
14. Fischer DR, Sun X, Gang G, Pritts T, Hasselgren PO. The gene expression of ubiquitin ligase E3α is upregulated in skeletal muscle during sepsis in rats - potential role of glucocorticoids. Biochem Biophys Res Commun 267: 504-508, 2000.
15. Flores EA, Bistrian BR, Pomposelli JJ, Dinarello CA, Blackburn GL, Istfan NW. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. J Clin Invest 83: 1614-1622, 1989.
16. Garcia-Martinez C, Llovera M, Agell N, Lopez-Soriano FJ, Argiles JM. Ubiquitin gene expression in skeletal muscle is increased during sepsis: involvement of TNFα but not IL-1. Biochem Biophys Res Commun 217: 839-844, 1995.
17. Giegerich R, Meyer C, Schleiermacher C. GeneFisher - software support for the detection of postulated genes. Proc Int Conf Intell Syst Mol Biol 4: 68-77, 1996.
18. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 98: 14440-14445, 2001.
19. Griffiths RD, Jones C, Palmer TE. Outcome of nutrition therapies in the intensive care unit. Nutrition 11: 224-228, 1995.
20. Hall-Angeeras M, Angeras U, von Allmen D, Higashiguchi T, Zamir O, Hasselgren PO, Fischer JE. Influence of sepsis in rats on muscle protein turnover in vivo and in tissue incubated under different in vitro conditions. Metabolism 40: 247-251, 1991.
21. Hamel FG, Upward JL, Siford GL, Dockworth WC. Inhibition of proteasome activity by selected amino acids. Metabolism 52: 810-814, 2003.
22. Hasselgren PO.Protein Metabolism in Sepsis. Austin, TX: RG Landes, 1993.
23. Hasselgren PO, James JH, Benson DW, Hall-Angeras M, Angeras U, Hiyama ET, Li S, Fischer JE. Total and myofibrillar protein breakdown in different types of rat skeletal muscle: effects of sepsis and regulation by insulin. Metabolism 38: 634-640, 1989.
24. Hasslegren PO, Wray C, Mammen J. Molecular regulation of muscle cachexia: it may be more than the proteasome. Biochem Biophys Res Commun 290: 1-10, 2002.
25. Hobler SC, Tiao G, Fischer JE, Monaco J, Hasselgren PO. Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors. Am J Physiol Regul Integr Comp Physiol 274: R30-R37, 1998.
26. 14k mRNA in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 276: R468-R473, 1999.
27. Kadoi Y, Saito S. An alteration in the gamma-aminobutyric acid receptor system in experimentally induced septic shock in rats. Crit Care Med 24: 298-305, 1996.
28. Lang CH. Sepsis-induced insulin resistance in rats is mediated by a β-adrenergic mechanism. Am J Physiol Endocrinol Metab 262: E703-E711, 1992.
29. Lang CH, Frost RA. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle. J Cell Physiol 203: 144-155, 2005.
30. Lang CH, Frost RA. Differential effect of sepsis on ability of leucine and IGF-I to stimulate muscle translation initiation. Am J Physiol Endocrinol Metab 287: E721-E730, 2004.
31. Lang CH, Fan J, Cooney R, Vary TC. Interleukin-1 receptor antagonist attenuates sepsis-induced alterations in the insulin-like growth factor system and protein synthesis. Am J Physiol Endocrinol Metab 270: E430-E437, 1996.
32. Lang CH, Frost RA, Jefferson LS, Kimball SR, Vary TC. Endotoxin-induced decrease in muscle protein synthesis is associated with alterations in eIF2B, eIF4E, and IGF-I. Am J Physiol Endocrinol Metab 278: E1133-E1143, 2000.
33. Lang CH, Frost RA, Nairn AC, MacLean DA, Vary TC. TNF-αdecreases myocardial and skeletal muscle protein synthesis by altering translation initiation. Am J Physiol Endocrinol Metab 282: E336-E347, 2002.
34. Lang CH, Silvis C, Nystrom G, Frost RA. Regulation of myostatin by glucocorticoids after thermal injury. FASEB J 15: 1807-1809, 2001.
35. Lang CH, Vary TC, Frost RA. Acute in vivo elevation in IGFBP-1 decreases plasma free IGF-I and muscle protein synthesis. Endocrinology 144: 3922-3933, 2003.
36. Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, Wei Y, Lin SC, Yancopoulos GD, Glass DJ. Insulin-like growth factor-I (IGF-I) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 280: 2737-2744, 2005.
37. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE, Goldberg AL. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18: 39-51, 2004.
38. Lecker SH, Solomon V, Mitch WE, Goldberg AL. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J Nutr 129: 227S-237S, 1999.
39. Lee SW, Dai G, Hu Z, Wang X, Du J, Mitch WE. Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol 15: 1537-1545, 2004.
40. Li BG, Hasselgren PO, Fang CH, Warden GD. Insulin-like growth factor-I blocks dexamethasone-induced protein degradation in cultured myotubes by inhibiting multiple proteolytic pathways. J Burn Care Rehabil 25: 112-118, 2004.
41. Li HH, Kedar V, Zhang C, McDonough H, Arya R, Wang DZ, Patterson C. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest 114: 1058-1071, 2004.
42. 20k. FASEB J 17: 1048-1057, 2003.
43. Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ, Argiles JM. TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun 230: 238-241, 1997.
44. Llovera M, Garcia-Martinez C, Costelli P, Agell N, Carbo N, Lopez-Soriano FJ, Argiles JM. Muscle hypercatabolism during cancer cachexia is not reversed by the glucocorticoid receptor antagonist RU38486. Cancer Lett 99: 7-14, 1996.
45. Matthews DE. Observations of branched-chain amino acid administration in humans. J Nutr 135: 1580S-1584S, 2005.
46. Mitch WE, Walser M, Sapir DG. Nitrogen sparing induced by leucine compared with that induced by its keto analogue, α-ketoisocaproate, in fasting obese man. J Clin Invest 67: 553-562, 1981.
47. Mizock BA. Metabolic derangements in sepsis and septic shock. Crit Care Clin 16: 319-336, 2000.
48. Nakashima K, Ishida A, Yamazaki M, Abe H. Leucine suppresses myofibrillar proteolysis by down-regulating ubiquitin-proteasome pathway in chick skeletal muscles. Biochem Biophys Res Commun 336: 660-666, 2005.
49. Roos-Mattjus P, Sistonen L. The ubiquitin-proteasome pathway. Ann Med 36: 285-295, 2004.
50. Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab 287: E591-E601, 2004.
51. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412, 2004.
52. Shah OJ, Kimball SR, Jefferson LS. Acute attenuation of translation initiation and protein synthesis by glucocorticoids in skeletal muscle. Am J Physiol Endocrinol Metab 278: E76-E82, 2000.
53. Svanberg E, Frost RA, Lang CH, Isgaard J, Jefferson LS, Kimball SR, Vary TC. IGF-I/IGFBP-3 binary complex modulates sepsis-induced inhibition of protein synthesis in skeletal muscle. Am J Physiol Endocrinol Metab 279: E1145-E1158, 2000.
54. Thompson MG, Thorn A, Partridge K, Garden K, Campbell GP, Calder G, Palmer RM. Simulation of myofibrillar protein degradation and expression of mRNA encoding the ubiquitin-proteasome system in C2C12 myotubes by dexamethasone: effect of the proteasome inhibitor MG-132. J Cell Physiol 181: 455-461, 1999.
55. Tiao G, Fagan J, Roegner V, Lieberman M, Wang JJ, Fischer JE, Hasslegren PO. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J Clin Invest 97: 339-348, 1996.
56. Tiao G, Lieberman MA, Fischer JE, Hasselgren PO. Intracellular regulation of protein degradation during sepsis is different in fast- and slow-twitch muscle. Am J Physiol Regul Integr Comp Physiol 272: R849-R856, 1997.
57. Tischler ME, Desautels M, Goldberg AL. Does leucine, leucyl-tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle? J Biol Chem 257: 1613-1621, 1982.
58. Vary TC, Kimball SR. Sepsis-induced changes in protein synthesis: differential effects on fast- and slow-twitch muscles. Am J Physiol Cell Physiol 262: C1513-C1519, 1992.
59. Windsor JA, Hill GL. Risk factors for postoperative pneumonia. The importance of protein depletion. Ann Surg 208: 209-214, 1988.
60. Wray CJ, Mammen JM, Hershko DD, Hasselgren PO. Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int J Biochem Cell Biol 35: 698-705, 2003.
61. Wray CJ, Sun X, Gang GI, Hasselgren PO. Dantrolene downregulates the gene expression and activity of the ubiquitin-proteasome proteolytic pathway in septic skeletal muscle. J Surg Res 104: 82-87, 2002.
62. Zamir O, Hasselgren PO, Frederick JA, Fischer JE. Is the metabolic response to sepsis in skeletal muscle different in infants and adults? An experimental study in rats. J Ped Surg 27: 1399-1403, 1992.